| [1] |
Oketani M, Ido A, Nakayama N, et al. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan:summary of the annual nationwide survey between 2004 and 2009[J]. Hepatol Res, 2013, 43(2):97-105. doi: 10.1111/hepr.2013.43.issue-2
|
| [2] |
Pattullo V. Hepatitis B reactivation in the setting of chemotherapy and immunosuppression-prevention is better than cure[J]. World J Hepatol, 2015, 7(7):954-967. doi: 10.4254/wjh.v7.i7.954
|
| [3] |
Shouval D, Shibolet O. Immunosuppression and HBV reactivation[J]. Semin Liver Dis, 2013, 33(2):167-177. doi: 10.1055/s-00000069
|
| [4] |
Kim E, Yune S, Ha JM, et al. Hepatitis B virus reactivation during anti-cancer chemotherapy in patients with past hepatitis B virus infection[J]. Hepatogastroenterology, 2014, 61(134):1704-1711. https://www.ncbi.nlm.nih.gov/pubmed/25436366
|
| [5] |
田沂, 龚国忠.乙型肝炎病毒再激活致肝衰竭病例及其机制分析[J].中华肝脏病杂志, 2014, 22(4):272-276. https://www.ncbi.nlm.nih.gov/pubmed/25173225
Tian X, Gong GZ. Fulminant hepatic failure and hepatitis B virus reactivation:case reports and analyses of the pathological mechanism[J]. Chin J Hepatol, 2014, 22(4):272-276. https://www.ncbi.nlm.nih.gov/pubmed/25173225
|
| [6] |
Mandala M, Fagiuoli S, Francisci D, et al. Hepatitis B in immunosuppressed cancer patients:pathogenesis, incidence and prophylaxis[J]. Crit Rev Oncol Hematol, 2013, 87(1):12-27. doi: 10.1016/j.critrevonc.2012.12.004
|
| [7] |
Cho JH, Lim JH, Park GY, et al. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection[J]. Transpl Infect Dis, 2014, 16(2):295-303. doi: 10.1111/tid.2014.16.issue-2
|
| [8] |
Hwang JP, Lok AS. Management of patients with hepatitis B who require immunosuppressive therapy[J]. Nat Rev Gastroenterol Hepatol, 2014, 11(4):209-219. https://www.ncbi.nlm.nih.gov/pubmed/24247262
|
| [9] |
John S, Andersson KL, Kotton CN, et al. Prophylaxis of hepatitis B infection in solid organ transplant recipients[J]. Therap Adv Gastroenterol, 2013, 6(4):309-319. doi: 10.1177/1756283X13487942
|
| [10] |
Seetharam A, Perrillo R, Gish R. Immunosuppression in patients with chronic hepatitis B[J]. Curr Hepatol Rep, 2014, 13:235-244. doi: 10.1007/s11901-014-0238-2
|
| [11] |
Schiller D, Schoefl R, Holzmann H. Fatal acute liver failure in a kidney-transplant recipient[J]. Gastroenterology, 2014, 146(1):36, 325. doi: 10.1053/j.gastro.2013.09.024
|
| [12] |
Gaber AO, Moore LW, Alloway RR, et al. Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal[J]. Transplantation, 2013, 95(4):573-579. doi: 10.1097/TP.0b013e3182777efb
|
| [13] |
Oketani M, Uto H, Ido A, et al. Management of hepatitis B virus-related acute liver failure[J]. Clin J Gastroenterol, 2014, 7(1):19-26. doi: 10.1007/s12328-013-0447-1
|
| [14] |
张永根, 肖都, 刘怡, 等.两种非生物型人工肝支持系统治疗重症肝衰竭的有效性和安全性[J].实用医学杂志, 2014, 30(15):2516-2517. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201415064.htm
Zhang YG, Xiao D, Liu Y, et al. Efficacy and safety of two kinds of non-biological artifical liver support system for the treatmant of severe liver failure[J]. J Pract Med, 2014, 30(15):2516-2517. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201415064.htm
|
| [15] |
Saliba F, Samuel D. Artificial liver support:a real step forward[J]. Minerva Med, 2015, 106(1):35-43. https://www.ncbi.nlm.nih.gov/pubmed/25367058
|
| [16] |
Zhou PQ, Zheng SP, Yu M, et al. Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system[J]. World J Gastroenterol, 2015, 21(32):9614-9622. doi: 10.3748/wjg.v21.i32.9614
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: